Tylosin Market Seeking Growth from Emerging Study Drivers, Restraints and Forecast 2026
Tylosin
is an antibiotic that belongs to the class of macrolide
antibiotics. It functions by binding to 50S ribosomal subunit and
then interacts with 23S RNA thereby blocking aminoacyl-tRNA, which in
turn inhibits protein synthesis. Tylosin is manufactured by
fermentation of the bacterium— Streptomyces fradiae and is most
effective against gram-positive bacteria compared to gram negative
bacteria. The antibiotics is used to treat various infections in
animals and respiratory infections in animals caused by Pasteurella
multocida, Mannheimia haemolytica, and Haemophilus spp.
According to a report by Canadian Food Inspection
Agency, 2014, 11 concentrations of tylosin used for therapeutic
purposes, range from 44 mg kg-1 to 110 mg kg-1 feed. Moreover,
tylosin is used in pigs to treat porcine proliferative enteropathy
caused by Lawsonia intracellularis — a Gram-negative bacterium.
Agriculture grade Tylosin consists of 80-90% tylosin A, with smaller
amounts of tylosin B, tylosin C, and tylosin D. Around 29% of the
active tylosin can be recovered in fecal samples in animals that
receive tylosin, orally.
Increasing demand for healthy livestock is
expected to support growth of global Tylosin market over the forecast
period
The demand for livestock animals for consumption
is on the rise worldwide and is expected to maintain the positive
growth in demand over the forecast period. Subsequently, the demand
for infection-free and healthy livestock used primarily for
consumption is increasing. However, the prevalence of various
microbial infections is high in both humans and animals. For
instance, according to the Centers for Disease Control and Prevention
(CDC), 2017, zoonotic diseases are common in the U.S. and worldwide
and over 6 out of every 10 known infectious diseases in humans are
spread from animals. Hence, antibiotics are an important medication
for livestock that aide in providing healthy food products for
consumption in humans.
Detailed Segmentation:
-
Global Tylosin Market, By Drug Type:
-
Tylosin Phosphate
-
Tylosin Tartrate
-
Others
-
-
Global Tylosin Market, By Application:
-
Felines
-
Canines
-
Livestock
-
Others
-
-
Global Tylosin Market, By Route Of Administration:
-
Oral
-
Injectable
-
-
Global Tylosin Market, By Geography:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
-
Global Key Players:
Key companies
covered as a part of this study include, Zoetis, Tairui
Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu
Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare
Pharma, and Elanco Animal Health.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment